value-based care

A new study examined post-treatment evaluation methods of head and neck squamous cell carcinoma in the context of advanced imaging and value-based care.
Adam M Brufsky, MD, PhD, discusses some of the key topics and data for examining the clinical and cost implications of HER-positive breast cancer care in the value-based care era.
Debra Patt, MD, MPH, MBA, spoke about the major issues affecting patients with cancer and community practices in the United States.
Following the dual-keynote presentations given by Ron Kline, MD, FAAP, and Lee N Newcomer, MD, MHA, a lively roundtable discussion took place on the NCCN stage regarding critical current and emerging issues in the delivery of cancer care in value-based care models.
The second presentation of the NCCN Annual Conference Keynote session was given by Lee N Newcomer, MD, MHA, a leading voice in the payer community, who spoke on cancer care delivery from the managed care perspective.
In the first presentation NCCN Annual Conference Keynote session, Ron Kline, MD, FAAP, gave an overview of the OCM and an unofficial preview of the preliminary data CMMI has accrued from OCM practices within the first 6 months of implementation.
Panelists shared their strategies of enhancing care coordination for patients in the transition toward value-based care planning.
The advantages of implementing technology into the daily operations of a community-based practice vary from finding inefficiencies in operational processes for identifying gaps to optimizing value-based care.
A session highlighted strategies for managing clinical trials for cancer and improving patient accrual in the community setting.
Where the Pathways Conversation Turns to Action